Transcription
SEARCHWELCOME TO ATS 2017 WASHINGTON, DCWelcome to ATS 2017Welcome to Washington, DC for the 2017 American Thoracic Society International Conference. Theconference, which is expected to draw more than 15,000 investigators, educators, and clinicians, istruly the destination for pediatric and adult pulmonary, critical care, and sleep medicine professionals atevery level of their careers.The conference is all about learning, networking and connections. Because it engages attendeesacross many disciplines and continents, the ATS International Conference draws a large, diverse groupof participants, a dedicated and collegial community that inspires each of us to make a difference inpatients’ lives, now and in the future. By virtue of its size — ATS 2017 features approximately 6,700original research projects and case reports, 500 sessions, and 800 speakers — participants can attendsessions and special events from early morning to the evening. At ATS 2017 there will be something foreveryone.David Gozal, MDPresidentAmerican Thoracic SocietyDon’t miss the following important events: Opening Ceremony featuring a keynote presentation by Nobel Laureate James Heckman,PhD, MA, from the Center for the Economics of Human Development at the University ofChicago.Ninth Annual ATS Foundation Research Program Benefit honoring David M. Center, MD,with the Foundation’s Breathing for Life Award on Saturday.ATS Diversity Forum will feature Eliseo J. Pérez-Stable, MD, Director, National Institute onMinority Health and Health Disparities at the National Institutes of Health.Keynote Series highlight state of the art lectures on selected topics in an unopposed formatto showcase major discoveries in pulmonary, critical care and sleep medicine.Respiratory Health Awards, which includes the Trudeau Medal, Distinguished AchievementAwards, and Amberson Lecture, given by Peter D. Pare, MD, of the University of BritishColumbia.ATS Plenary Session will feature a talk by Marc L. Busch, PhD, the Karl F. LandeggerProfessor of International Business Diplomacy at the School of Foreign Service, GeorgetownUniversity.Assembly Membership Meetings, which are open to all attendees.These events create a sense of community among the International Conference attendees, which isprecisely what our founders had hoped when they established the world’s first respiratory society.Zea Borok, MDChairInternational ConferenceCommitteeFinally, we wish to acknowledge the hard work and outstanding efforts of the members of theInternational Conference Committee, Education Committee, Assembly Program Committees, andATS staff. The success of our conference depends on the dedication, creativity, and support of theseindividuals. We welcome you to the International Conference and hope you take advantage of allWashington has to offer.INTERNATIONAL CONFERENCE COMMITTEEZea Borok, MD, Chair 2015-2017Jess Mandel, MD, Chair 2017-2019JiYeon Choi, PhD, RNColin R. Cooke, MDSonye K. Danoff, MD, PhDLaura C. Feemster, MSc, MDAndrew P. Fontenot, MDMichelle N. Gong, MS, MDDavid Gozal, MD, MBATillie-Louise Hackett, BS(Hons), PhDAnna Hemnes, MDATS 2017 Washington, DCAnastassios C. Koumbourlis, MD, MPHTim Lahm, MDPatty Lee, MDTricia D. LeVan, PhDAugusto A. Litonjua, MDWilliam Man, MD, PhDMark L. Metersky, MDPaul E. Moore, MDMarc Moss, MDMarilyn Moy, MD, MScRobert L. Owens, MDKaren M. Ridge, PhDJussi J. Saukkonen, MDFrank C. Sciurba, MDGwen S. Skloot, MDChristopher G. Slatore, MDAnne I. Sperling, PhDRenee D. Stapleton, MD, PhDLynn T. Tanoue, MDEsra Tasali, MDJudith Tate, PhD, RNAtul Malhotra, MD
SEARCHTABLE OF CONTENTSATS 2017 INTERNATIONAL CONFERENCEMAY 19-24WASHINGTON, D.C.This year the session portion of the Final Program for the ATS InternationalConference is available in printed and digital format. This publication contains theprograms and speakers for the postgraduate courses, scientific and educationalsessions presented at the conference.You can download this PDF, the Conference APP or access the program via theonline program itinerary.11021129246356Friday Postgraduate CoursesSaturday Postgraduate CoursesSunday Conference SessionsMonday Conference SessionsTuesday Conference SessionsWednesday Conference SessionsThe information contained in this program is up to date as of March 9, 2017. For the mostcurrent session information, please visit the online program itinerary.
SEARCHCONFERENCE PLANNERS DISCLOSURESIn accordance with the ACCME Standards for Commercial Support, and those of the ATS Policy on Management of Conflict of Interest in Official ATSDocuments, Projects and Conferences, ATS Policy Governing Relationships Between the Tobacco Industry, ATS Members, and Non-Members Who Participate inATS Activities, and ATS Policy on Professionalism and Ethical Conduct chairs, moderators, presenters and official planners of the International Conference arerequired to disclose to ATS any potential conflicts of interest (COI) held by them or their spouse/life partner relevant to their presentation(s) or conference role,including all professional or other financial involvement with tobacco or e-cigarette entities, all relevant financial relationships with commercial interests, andall other relationships that could be perceived as influencing their participation. Conference presenters are also asked to disclose if there will be any discussionin the presentation of “off-label” (unapproved) use of substances/products not approved in the United States for the use under discussion (as per the U.S. Foodand Drug Administration Guidance for Industry: Industry-Supported Scientific and Educational Activities).For the 2017 International Conference, this disclosure information for all individuals in control of content was requested and received by ATS in advance ofthe Conference, reviewed by appropriate ATS reviewers, and session chairs and others in positions of authority were instructed to manage (resolve) identifiedfaculty conflicts according to procedures overseen by the ATS Ethics and Conflict of Interest Committee.To access the disclosures made by the faculty of the 2017 International Conference, please go to http://conference.thoracic.org/speakersThe following members of the Education Committee have disclosed no financial relationships with commercial interests:Debra M. Boyer, MD, ChairJason T. Poston, MD, Vice ChairGaetane C. Michaud, MD, Vice ChairMark K. Abe, MDShozab Ahmed, MBBSWilliam G. Carlos, MDAlison S. Clay, MDWalter D. Conwell, MDDaniel R. Crouch, MD, MSDorAnne M. Donesky, PhD, ANP-BCGarth Garrison, MDDavid Gozal, MD, MBAMargaret M. Hayes, MDAmjad Horani, MDShazia M. Jamil, MDCarl A. Kaplan, MDJack KellyDenay P. Kirkpatrick, DNPAbagail R. Lara, MDMoishe Liberman, MD, PhDAndrew Luks, MDPatrick Lyons, MDSamir Makani, MDAtul Malhotra, MDJakob I. McSparron, MDPaul E. Moore, MDMarc Moss, MDViswam S. Nair, MSCR, MDJeremy E. Orr, MDSusan Pasnick, MDJessica E. Pittman, MD, MPHAllan J. Walkey, MD, MScTisha S. Wang, MDCarolyn H. Welsh, MDLisa F. Wolfe, MDThe following members of the Education Committee have disclosed the following financial relationships with commercial interests:Caralee E. Caplan-Shaw, MD: AristaMDand Cohero Health (Consultant); BardPeripheral Vascular, Inc. and VeranMedical Technologies (Food/BeverageOnly); Cook Incorporated (Food/Beverage Only, Spouse-CME Speaker);MedImmune, Novartis Pharma andTeva Pharmaceuticals USA (ResearchSupport); Myriad Genetic Laboratories(Spouse-Consultant)Colleen L. Channick, MD: ActelionPharmaceuticals US and BayerHealthCare Pharmaceuticals (SpouseConsultant); Medtronic and OlympusCorporation of the Americas (Consultant)Charles Dela Cruz, MD, PhD: Cempra(Advisory Committee); Sanofi-AventisU.S. (Consultant)Samaan Rafeq, MD: Boston Scientific(Consultant, Speaker); Veran Medical(Consultant)Jordan S. Rettig: Boston’s ChildrenHospital (Intellectual Property NotCommercialized)Mary E. Strek, MD: BoehringerIngelheim Pharmaceuticals (Dataand Safety Monitoring Board,Research Support); Gilead Sciences,InterMune, MedImmune, and VertexPharmaceuticals (research support)Bishoy Zakhary, MD: ELSO ECMO TrainingCourses and ACCP (Course Instructor)The following members of the International Conference Committee have disclosed no financial relationships with commercial interests:Zea Borok, MD, ChairJess Mandel, MD, Chair AppointeeJiYeon Choi, PhD, RNColin R. Cooke, MDSonye K. Danoff, MD, PhDLaura C. Feemster, MSc, MDAndrew P. Fontenot, MDMichelle N. Gong, MD, MSDavid Gozal, MD, MBATillie-Louise Hackett, PhDAnastassios C. Koumbourlis, MD, MPHPatty Lee, MDTricia D. LeVan, PhDAtul Malhotra, MDWilliam Man, MD, PhDPaul E. Moore, MDMarc Moss, MDMarilyn Moy, MD, MScRobert L. Owens, MDKaren M. Ridge, PhDJussi J. Saukkonen, MDGwen S. Skloot, MDChristopher G. Slatore, MDAnne I. Sperling, PhDRenee D. Stapleton, PhD, MDLynn T. Tanoue, MDEsra Tasali, MDJudith Tate, PhD, RNThe following members of the International Conference Committee have disclosed the following financial relationships withcommercial interests:Anna Hemnes, MD: ActelionPharmaceuticals, US and UnitedTherapeutics Corporation (AdvisoryCommittee); Pfizer, Inc. (ExpertTestimony)ATS 2017 Washington, DCTim Lahm, MD: Bayer HealthCarePharmaceuticals (Speaker); GileadSciences and Pfizer AG (ResearchSupport)Augusto A. Litonjua, MD: AstraZenecaPharmaceuticals (Advisory Committee);Springer Humana Press and UpToDate(author)Mark L. Metersky, MD: Aradigm and Bayer(Research Support); EBSCO (Consultant);Grifols (Advisory Committee)Frank C. Sciurba, MD: BoehringerIngelheim b.v. (Advisory Committee);BTG and Pulmonx Corporation (ResearchSupport)
SEARCHFRIDAY MAY 191Welcome & Introduction to Critical Care Ultrasound:Training and CompetencyM.J. Lanspa, MD, MS, Salt Lake City, UT8:15Basic Physics, Artifacts, KnobologyZ. Shaman, MD, Cleveland, OH8:45Transthoracic Windows and ViewsA. Leibowitz, MD, Boston, MA9:15Basic Evaluation of LV Systolic Function, Measurement ofCardiac OutputS. Price, MBBS, PhD, EDICM, London, United Kingdom9:45Basic Evaluation of RV Size and Function, the RV inPulmonary DiseaseD. Pradhan, MD, New York, NY10:15Break10:30Practical Skills Sessions: Hands-On Station IApical WindowX. Monnet, MD, PhD, Paris, FranceT. Brakke, MD, Omaha, NEZ. Shaman, MD, Cleveland, OHL. Grecu, MD, Stony Brook, NYCLINICALRPOSTGRADUATE COURSECME Credits Available: 7PG1AParasternal WindowP. Mohabir, MD, Stanford, CAG.B. Allen, MD, Burlington, VTJ. Kasal, MD, St. Louis, MOS. Price, MBBS, PhD, EDICM, London, United KingdomD. Pradhan, MD, New York, NYCRITICAL CARE ULTRASOUND ANDECHOCARDIOGRAPHY IThis is part 1 of a two-part course which includes PG1B on Saturday, May 20.Those registering for PG1A will be registered for PG1A and PG1B.Pre-registration and additional fees required. Continental breakfast andbox lunch included. Attendance is limited.Subcostal WindowM. Hunter-Behrend, MD, Tacoma, WAL. Rapoport, MD, Santa Clara, CAV.A. Dinh, MD, Loma Linda, CAE. Teo, MD, Atlanta, GAJ. Pittman, MD, Salt Lake City, UTMember: 900In-Training Member: 675Non-Member: 1,200In-Training Non-Member: 775: Registrants must bring a laptop to thecourse to view the course material.Assembly on Critical Care12:00LUNCH12:30Lunch and Clinical Cases IL. Grecu, MD, Stony Brook, NYTarget AudienceProviders of critical care or emergency medicine12:45Chest UltrasoundP. Mohabir, MD, Stanford, CAObjectivesAt the conclusion of this session, the participant will be able to:1:15Basic ValvulopathyT. Brakke, MD, Omaha, NE apply ultrasound at bedside to assess critically ill patients;1:45Basic Assessment of Diastolic FunctionC.K. Grissom, MD, Murray, UT apply ultrasound to guide common ICU procedures.2:15BreakThis is a 2-day postgraduate course that consists of didactic lectures and hands-onstations. The focus is primarily bedside transthoracic echocardiography, with somediagnostic ultrasound. The topics include basic and intermediate critical careechocardiography (including hemodynamic measures), assessment of fluid status,procedural guidance for vascular access and thoracentesis, venography. Thehands-on stations will include both healthy models and simulators that candemonstrate abnormal pathology.2:30Practical Skills Sessions: Hands-On Station II8:00 a.m. - 4:00 p.m.WALTER E. WASHINGTON CONVENTION CENTERRoom 145 A (Middle Building, Street Level) diagnose alternate etiologies of shock in the critically ill patient;Lung Ultrasound (Model and Management)P. Mohabir, MD, Stanford, CAL. Rapoport, MD, Santa Clara, CAM. Hunter-Behrend, MD, Tacoma, WAZ. Shaman, MD, Cleveland, OHD. Pradhan, MD, New York, NYChairing: M.J. Lanspa, MD, MS, Salt Lake City, UTX. Monnet, MD, PhD, Paris, FranceThe information contained in this program is up to date as of March 9, 2017.For the most current session information, please visit the online program itinerary.ATS 2017 Washington, DCFRIDAYFriday, May 198:00
SEARCH2FRIDAY MAY 19Diastolic MeasurementsJ. Pittman, MD, Salt Lake City, UTT. Brakke, MD, Omaha, NES. Price, MBBS, PhD, EDICM, London, United KingdomX. Monnet, MD, PhD, Paris, FranceA. Leibowitz, MD, Boston, MACardiac OutputL. Grecu, MD, Stony Brook, NYV.A. Dinh, MD, Loma Linda, CAJ. Kasal, MD, St. Louis, MOE. Teo, MD, Atlanta, GAG.B. Allen, MD, Burlington, VTRBASIC TRANSLATIONALPOSTGRADUATE COURSECME Credits Available: 6.5PG2HOW TO USE ‘OMICS TO STUDY LUNG DISEASEPre-registration and additional fees required. Continental breakfast andbox lunch included. Attendance is limited.Member: 350In-Training Member: 200Non-Member: 425In-Training Non-Member: 300: Registrants must bring a laptop to thecourse to view the course material.Assemblies on Allergy, Immunology and Inflammation; Respiratory Celland Molecular Biology; Respiratory Structure and Function; ThoracicOncology; Genetics and Genomics Section8:00 a.m. - 4:00 p.m.WALTER E. WASHINGTON CONVENTION CENTERRoom 152 A (Middle Building, Street Level)Target AudienceLung researchers interested in applying so called ‘omics based approaches, whichfrequently rely on the deep sequencing revolution, to study all aspects of the lungincluding diseaseObjectivesAt the conclusion of this session, the participant will be able to: gain new findings about how genome wide studies of gene expressionenhance the understanding of lung disease; learn practical approaches to using existing genome wide data sets to studylung disease and improve patient care.The ‘omics revolution continues full speed and is transforming the approach tobasic and translational research on lung disease. However, it can be difficult togain even a working familiarity with many of the key techniques in this rapidlychanging field. This course will provide a practical overview of the latest in‘Omics-based techniques and how they can be applied to study lung disease.Topics will include genetics, transcriptomics, single-cell analysis, phenomics,deep sequencing-based methodologies to study gene regulation, includingChIP-seq and Atac-seq, and an overview of statistical approaches and mining ofpublicly available ‘Omics data.Chairing: B.E. Himes, PhD, Philadelphia, PAA.N. Gerber, MD, PhD, Denver, COM.M. Wurfel, MD, PhD, Seattle, WAATS 2017 Washington, DC8:00IntroductionM.M. Wurfel, MD, PhD, Seattle, WA8:20Common Themes of ‘Omics StudiesP.G. Woodruff, MD, MPH, San Francisco, CA8:55Analyzing RNA Using OmicsB.A. Raby, MD, MPH, Boston, MA9:30Break9:45Single Cell TranscriptomicsT.J. Desai, MD, Stanford, CA10:20Integrating Genomics and TranscriptomicsD. Meyers, PhD, Winston-Salem, NC10:55Methylomics and the LungI. Yang, PhD, Aurora, CO11:30General Discussion11:45LUNCH12:45ChIP-Seq: Studying the Pulmonary CistromeA.N. Gerber, MD, PhD, Denver, CO1:20Ataq-Seq and Other Genome Wide Methods of StudyingChromatinR. Bauer, PhD, South San Francisco, CA1:55Break2:10The Public Domain: Exploiting Existing DatasetsN. Bhakta, MD, PhD, San Francisco, CA2:40Omics: A Statistical and Computational OverviewB.E. Himes, PhD, Philadelphia, PA3:30Summary and General DiscussionA.N. Gerber, MD, PhD, Denver, CORBEHAVIORAL CLINICALPOSTGRADUATE COURSECME Credits Available: 7PG3LOOK BEFORE YOU LEAP: SKILLS FOR CRITICALEVALUATION OF CLINICAL RESEARCHPre-registration and additional fees required. Continental breakfast andbox lunch included. Attendance is limited.Member: 400In-Training Member: 250Non-Member: 475In-Training Non-Member: 350: Registrants must bring a laptop to thecourse to view the course material.Assemblies on Behavioral Science and Health Services Research;Allergy, Immunology and Inflammation; Clinical Problems; Critical Care;Environmental, Occupational and Population Health; Nursing; Pediatrics;Pulmonary Circulation; Pulmonary Rehabilitation; Sleep and RespiratoryNeurobiology and Thoracic Oncology8:00 a.m. - 4:00 p.m.WALTER E. WASHINGTON CONVENTION CENTERRoom 204 B-C (South Building, Level 2)Target AudienceAll health care providersThe information contained in this program is up to date as of March 9, 2017.For the most current session information, please visit the online program itinerary.
SEARCHFRIDAY MAY 193 learn reasoning behind specific design and analytic approaches mostcommonly used in quantitative interventional and observational studies, aswell as qualitative research;12:50CON: Clinical Practice Guidelines,“Genius Abhors aConsensus”B.P. Kavanagh, MD, Toronto, Canada1:15Small Group Discussion IA.J. Walkey, MD, MSc, Boston, MAA.B. Mehta, MD, Denver, COM. Hua, MD, MSc, New York, NYH.B. Gershengorn, MD, Bronx, NYR. Parke, RN, PhD, Auckland, New ZealandJ. Brozek, MD, PhD, Hamilton, CanadaB.P. Kavanagh, MD, Toronto, CanadaR. Zarychanski, MD, Winnipeg, CanadaK.A. Riekert, PhD, Baltimore, MD3:15Small Group Discussion II: Putting It All TogetherA.J. Walkey, MD, MSc, Boston, MAA.B. Mehta, MD, Denver, COM. Hua, MD, MSc, New York, NYH.B. Gershengorn, MD, Bronx, NYR. Parke, RN, PhD, Auckland, New ZealandJ. Brozek, MD, PhD, Hamilton, CanadaB.P. Kavanagh, MD, Toronto, CanadaR. Zarychanski, MD, Winnipeg, CanadaK.A. Riekert, PhD, Baltimore, MD better able to identify the strengths and limitations of design choices andsubsequent results obtained from clinical studies; apply a systematic approach to evaluating and analyzing the quality ofclinical studies in the medical literature to guide decisions for uptake ofevidence into your practice.Which studies should change your clinical practice? This session will combinedidactics with a workshop to provide a toolkit for clinicians to develop asystematic approach to evaluating the primary clinical research literature.Attendees will interact with clinical researchers and evidence based medicineexperts during didactic sessions to learn the elements that characterize qualityinterventional, observational, and qualitative studies. During two afternoon smallgroup workshops, participants will break out into three rotating small groups with1-2 faculty members to 1) participate in mini-journal clubs for RCT,observational, and qualitative research “case studies”; and 2) develop apersonal strategy to assess the quality of clinical research for adoption intopractice.Each participant should leave the session with a better understanding of both arigorous approach to evaluating the literature, as well as the internal andexternal influences that result in their own decisions to change practice.Chairing: A.J. Walkey, MD, MSc, Boston, MAH.B. Gershengorn, MD, Bronx, NY8:00IntroductionA.J. Walkey, MD, MSc, Boston, MA8:05RCT Basics: “Establishing the Gold Standard”R. Parke, RN, PhD, Auckland, New Zealand8:35RCTS: “All that Glitters”J.A. Krishnan, MD, PhD, Chicago, IL9:05General Discussion9:15Break9:25Observational Outcomes Research: “You Can Observe a LotJust by Watching”H.B. Gershengorn, MD, Bronx, NY9:50Comparative Effectiveness: “Identifying Who’s Doing ThingsRight, so You Can Do the Right Things”A.J. Walkey, MD, MSc, Boston, MARBASIC BEHAVIORAL CLINICAL TRANSLATIONALPOSTGRADUATE COURSECME Credits Available: 7.25PG4INTERSTITIAL LUNG DISEASE: CURRENT TRENDSIN
sessions and special events from early morning to the evening. At ATS 2017 there will be something for everyone. Don’t miss the following important events: Opening Ceremony featuring a keynote presentation by Nobel Laureate James Heckman, PhD, MA, from the Center for the Eco
